Path: ...!weretis.net!feeder9.news.weretis.net!news.nk.ca!rocksolid2!i2pn2.org!.POSTED!not-for-mail
From: manta103g@gmail.com (darius)
Newsgroups: soc.culture.polish
Subject: Re: Wirus atakuje =?UTF-8?B?UG9sYWvDs3c=?=
Date: Mon, 4 Nov 2024 20:20:30 +0000
Organization: novaBBS
Message-ID: <4b317b5c99460fc71c1816ccf3c0cd1c@www.novabbs.com>
References: <vgb6vo$2i3la$1@paganini.bofh.team>
MIME-Version: 1.0
Content-Type: text/plain; charset=utf-8; format=flowed
Content-Transfer-Encoding: 8bit
Injection-Info: i2pn2.org;
	logging-data="957992"; mail-complaints-to="usenet@i2pn2.org";
	posting-account="2ziXmaI3LavkZj56FXjLrM7mC0F1I2GCdPVHQb5yvsw";
User-Agent: Rocksolid Light
X-Rslight-Posting-User: 489b6c3a5945b08c369609b0686e9eb2a340a22d
X-Spam-Checker-Version: SpamAssassin 4.0.0
X-Rslight-Site: $2y$10$D2LRzTNiD1Px.rf0L3tVdu4tpAmH4psTXTdxYuq/PE6gl92V3Br3e
Bytes: 4646
Lines: 69

Covid się skonczył w 2022 roku i już nigdy nie powróci do Polski, gdyż
Polacy uzyskali odporność stadną, która jest trwała przez co najmniej 7
lat.

Nie ma też grypy od 30 lat
Nie ma też kataru
Nie ma kaszlu

Czyli przeziębiebnia zostały skutecznie wyeliminowane.

To wynika z raportów WHO

--

The recent, updated COVID-19 vaccine rollout in Poland, which began on
October 25, has seen disappointingly low turnout, with only around
90,000 people receiving it thus far. This limited uptake concerns
medical professionals, especially given the severity of COVID-19
complications and expected spikes in respiratory illnesses during
winter. The updated Spikevax JN.1 vaccine was introduced as part of a
strategic effort to address seasonal increases in infections and prepare
for potential surges in COVID-19 cases due to new variants.

One reason behind this low turnout may be the delayed availability of
the vaccine. According to Dr. Bożena Janicka, head of the Association of
Health Care Employers, many people initially showed interest when no
updated vaccine was accessible; however, now that it is widely
available, the interest appears to have dissipated. Dr. Janicka, who
practices family and pediatric medicine, expressed serious concern that
the limited interest could lead to increased patient health
complications, overwhelming clinics and hospitals during the high-risk
winter season. She mentions that some people are hesitant, responding
with vague intentions to "think about it" or "consider it," which
contributes to a generally low demand for COVID-19 and influenza
vaccines alike.

Health experts, like clinical pharmacologist Dr. Leszek Borkowski,
former president of the Office for Registration of Medicinal Products,
warn that underestimating COVID-19’s impact could lead to severe health
problems. Even though many now view COVID-19 as a milder virus
comparable to the flu, doctors observe that COVID-19 can result in
prolonged recovery periods of two to four weeks and additional risks of
respiratory failure and other severe conditions, especially in older
adults or those with pre-existing health issues. For patients with
compromised respiratory function or existing health issues, infection
can cause critical complications, a concern heightened by rising
COVID-19 cases in Warsaw hospitals.

Moreover, Dr. Janicka points out the broader implications of this trend,
emphasizing that low vaccination rates not only endanger individual
health but also give viruses more opportunities to mutate. With fewer
people vaccinated, there is a risk that the COVID-19 virus may evolve
into more harmful forms, similar to the cyclical changes observed in flu
viruses every decade or so. This risk of mutation is particularly
troubling when combined with low flu vaccination rates, as the two
infections could cause a "double wave" of severe respiratory illnesses
this winter.

In light of these conditions, both Dr. Janicka and Dr. Borkowski are
urging the public to consider vaccination as a preventive measure. The
challenges are significant: low public confidence, a general sense of
pandemic fatigue, and possibly a shift in perception of COVID-19 as a
non-threatening virus. However, the urgency remains, with health experts
advocating for proactive vaccination to mitigate the risks of widespread
illness, increased hospitalizations, and potentially severe long-term
health outcomes that may not fully emerge until years later.

The situation underscores a critical need for renewed public health
messaging and education about the continuing risks of COVID-19,
especially as the virus and its complications evolve.